Drug intelligence / Profile preview

PopVax HPV vaccine

Development stage: Preclinical
Lead developer: PopVax
Modality: mRNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Vaccines & Immunotherapeutics
Administration: Intramuscular

Overview

PopVax's HPV vaccine is an investigational mRNA-encoded virus-like particle (VLP) vaccine designed for the prevention of Human Papillomavirus (HPV) infection and associated cervical cancer. Developed by the Indian biotechnology company PopVax, the vaccine utilizes a proprietary mRNA platform to deliver genetic instructions that cause host cells to express HPV antigens. These antigens are designed to self-assemble into VLPs *in vivo*, mimicking the structure of the virus to elicit a potent immune response without the risk of infection. This approach aims to combine the rapid manufacturing advantages of mRNA technology with the high immunogenicity typically associated with VLP-based vaccines. As of early 2024, the program is in the design phase, with Phase 1 clinical trials anticipated to commence in 2028.

Other names: HPV vaccine (PopVax)PopVax Human Papillomavirus vaccine

Beyond the preview

Go deeper on PopVax HPV vaccine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PopVax HPV vaccine.

Explore the full profile